In another inflection point for the psychedelic medicines category, Mind Medicine (MindMed) has claimed breakthrough status from the FDA for its LSD-based candidate MM120 as a treatment for anxiety.

GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal.

Alexander Isak set for bumper Newcastle offer amid transfer interest, Barcelona seek Marcus Rashford loan - Paper Talk. Plus: Barcelona boss Hansi Flick is keen on recruiting Manchester United ...

Top science stories featured on ScienceDaily's home page. Tuesday, June 24, 2025. USC's New AI Implant Promises Drug-Free Relief for Chronic Pain ...

June 25, 2025 — A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner diversity. This insight could transform how we treat ...